Quantitative Monitoring of Circulating Epstein-Barr Virus DNA for Predicting the Development of Posttransplantation Lymphoproliferative Disease
✍ Scribed by Shouichi Ohga; Eiji Kubo; Akihiko Nomura; Hidetoshi Takada; Naohiro Suga; Eiichi Ishii; Aiko Suminoe; Takeshi Inamitsu; Akinobu Matsuzaki; Naoki Kasuga; Toshiro Haraa
- Publisher
- Carden Jennings Publishing
- Year
- 2001
- Tongue
- English
- Weight
- 79 KB
- Volume
- 73
- Category
- Article
- ISSN
- 0925-5710
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Epstein‐Barr virus (EBV)‐associated post‐transplant lymphoproliferative disease is a life‐threatening complication following hematopoietic stem cell transplantation. A quantitative polymerase chain reaction to evaluate EBV‐genome copy numbers based on a nested polymerase chain reaction
## Abstract ## BACKGROUND Patients with International Union Against Cancer (UICC) Stage I–II nasopharyngeal carcinoma (NPC) appear to have a relatively favorable prognosis and generally are excluded from trials of combined modality treatment. More recently, plasma/serum cell‐free Epstein‐Barr viru
## Abstract The physical state of the intracellular Epstein‐Barr virus DNA was characterized in four human lymphoblastoid cell lines, F‐265, NC‐37, U‐303 L, and PG‐1, derived from individuals without lympho‐proliferative disease. For comparison, a previously investigated Burkitt lymphoma line, Raji
## Abstract ## BACKGROUND The importance of detecting recurrence at an early stage in patients with malignant disease is well recognized. Circulating Epstein–Barr virus (EBV) DNA can be detected in patients with nasopharyngeal carcinoma (NPC). The objective of the current study was to assess the e